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ABSTRACT
Here we report the influence of aging on multiple markers of oxidativenitrosative stress in the heart of adult (6-month), aged (30-month) and very aged (36month) Fischer 344/NNiaHSd X Brown Norway/BiNia (F344/NXBN) rats. Compared to
6 month old rat hearts, indices of oxidative (superoxide anion (–O2·), 4-hyrdoxy-2nonenal (4-HNE)) and nitrosative (protein nitrotyrosylation) stress were 34.1 ± 28.1%,
186 ± 28.1% and 94 ± 5.8% higher, respectively, in 36-month hearts and these findings
were highly correlated with increases in left ventricular wall thickness (r>0.669; r>0.710
and p<0.01, respectively). Regression analysis showed that increases in cardiac
oxidative-nitrosative stress with aging were significantly correlated with changes in the
expression and/or regulation of proteins involved in transcriptional (NF-κB) activities,
signaling (mitogen activated protein kinases along with Src), apoptotic ( Bcl-2, Traf-2),
and cellular stress (HSPs). These results suggest that the aging F344/NXBN heart may
be highly suited for unraveling the molecular events that lead to age-associated
alterations in cardiac oxidative stress.
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Chapter 1
Introduction
The development of science and modern medical technology has resulted in
longer life spans and therefore, the aged population is increasing exponentially[1].
However, according to the Center of Disease Control (CDC), approximately 80% of aged
populations have at least one chronic condition, and 50% have at least two conditions
resulting in the majority of developed countries facing serious health concerns including
cancers, cardiovascular diseases, metabolic disorder, and neuromuscular impairment.
Within a few decades, the burden of health care costs will inflate colossally due to the
increasing demands of the elderly population[2].
Aging, defined as a gradual decline of the fighting ability of the organism against
stress, damage and diseases, is intuitively considered invincible; however recent studies
are attempting to shed new light on some of the possible mechanisms of aging[3-5]. One
of the most well known theories is oxidative stress theory which indicates that the
overproduction of free radicals damage lipids, proteins, and DNA during respiration[4,
5]. Since Harman proposed the free radical theory of aging a half century ago, there has
been growing evidence that suggests reactive oxygen species may play a crucial role in
aging[3, 6-8].
Reactive oxygen species are a family of free radicals including superoxide (·O2-),
hydroxyl radical (OH·) and hydrogen peroxide (H2O2) that are produced as a result of
cellular metabolism such as respiration[5]. Although reactive oxygen species are
produced in approximately 1 to 2 % of consumed oxygen during the respiration, under
normal physiological conditions, superoxide (·O2-) is converted to the H2O2 by the
1

superoxide dismutase (SOD) and eventually the H2O2 is converted in to H2O with
presence of the catalase and glutathione peroxidase[9]. Yet, abnormal oxidative stress
that is caused by the accumulation of free radicals may play a role in the initiation or
progression of chronic diseases such as metabolic syndrome, type II diabetes, cancer, and
neurological disorders [5, 10-12]. Although the exact mechanism of redox disruption is
not clear, the free radical theory points out increased amounts of superoxide (·O2-) and
deceased amounts of nitric oxide formation (NO) or its bioavailability with aging as
strong candidates[3]. Whether the disruption of redox balance is caused by
overproduction of ROS, antioxidant deficiency, or a combination of the two, it will result
in serious damage to the cell which may eventually lead to chronic diseases or aging.
Nevertheless, these reactive oxygen species, under ideal circumstances, can have
a positive effect on organisms. For instance, reactive oxygen species, ·O2- , NO are
intentionally formed to regulate cell signal process[13-15]. Specifically, several cell
signal transductions may require the involvement of ROS-dependent activation to
regulate a variety of cellular function such as cell signaling, metabolic, apoptotic, and
transcriptional activities[15-17].
Although ROS seem to play a crucial role in cardiac ischemic and reperfusion
injury and possibly the initiation of arrhythmias[18], how ROS might induce these events
and also the normal level of ROS needed for cell signal transduction remain unknown. A
recent study has shown that a strong association exists between the amount of ROS and
aging in the F344/NXBN rat aorta and this increased ROS was correlated with the
expression of several proteins[19]. Ushio-Fukai, M., et al found the H2O2 is associated
with the phosphrylation of p42/44 mitogen-activated protein kinases (MAPK) and p38
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MAPK in vascular smooth muscle cell[20]. On the other hand, AMP activated protein
kinase (AMPK) which is known to play a key role in the metabolic regulation, and a
study performed with cell culture suggest that intracellular ROS may activate AMPK in
adipose cells[21]. Nuclear factor kappa beta (NF-κB) may suppress the accumulation of
ROS that mediates an additional protective activity[22]. Transient oxidative stress
contributes to progressive apoptosis that results in chronic condition[23].
Considering these studies, ROS are definitely involved in the cell signal
transduction both intentionally and unintentionally, which may cause either beneficial or
detrimental results. Previous study using the Fischer 344/NNiaHSd X Brown
Norway/BiNia (F344/NXBN) rat has demonstrate that aged F344/NXBN rat aorta was
significantly correlated with ROS and several signal molecules, nevertheless it is not
known whether a similar correlation exists in the F344/NXBN rat cardiac muscle[19].
Thus, this study was conducted to determine whether aging affects the presence of ROS
in the rat heart, and secondly, to establish the correlation among ROS and signal
molecules that may be associated with oxidative stress and morphological alterations.

3

Hypothesis/Purpose of study
The purpose of this study was to determine how aging affects multiple,
previously identified markers of oxidative-nitrosative stress in the rat heart. We
hypothesized that aging would be associated with increases in the cardiac content or basal
phosphorylation of oxidative-nitrosative stress markers.

Specific Aim 1
To determine if aging in the F344/NXBN heart is associated with increased ROS.

Hypothesis
We hypothesize that aging will be associated with increased indices of cardiac
ROS.

Specific Aim 2
To determine how aging affects multiple, previously identified markers of oxidativenitrosative stress in the F344/NXBN rat heart.

Hypothesis
We hypothesize that age-associated increases in ROS will be strongly associated
with indices of oxidative-nitrosative stress in the aging F344/NXBN heart.

4

Significance of the study
Increased age is the primary risk factor for the development of cardiac and
vascular disease. It is theorized that the initiation and progression of aging is strongly
related to ROS, however the molecular target(s) of ROS remains to be elucidated. A
better understanding of the relationship between aging and cardiac ROS may provide
insight into how aging may affect cardiovascular structure, function and disease
development.

5

Chapter 2
Review of Literature
This chapter will describe the literature regarding age associate cardiovascular
alteration, ROS, and ROS in the cardiovascular system.

Age associated cardiovascular change
One of the highest causes of death in the aged population is cardiovascular
diseases that include coronary artery atherosclerosis, hypertension, chronic heart failure,
and congestive heart failure. Recent studies have found that the elderly population
experiences the following cardiovascular related changes; left ventricular hypertrophy
(LVH), altered hemodynamic, arrhythmia, and valvular disease[24, 25]. Specifically,
even with the absence of disease conditions, the aged heart revealed modest increases in
heart mass, particularly in left ventricular and interventricular septal wall thickness
because of the increased size of myocytes[26]. A major issue in common age associated
hemodynamic changes is isolated systolic hypertension due to increased systolic blood
pressure and decreased diastolic blood pressure[27]. Additionally, altered ventricular
relaxation and abnormal ventricular filling are the hallmarks of diastolic heart failure[28].
As a compensatory mechanism of hypertension, LVH is common in patients with high
blood pressure. Atrial Fibrillation(AF), represented by atrial depolarization issues, one of
the common arrhythmia seen in elderly polulation[29], may be caused by a calcification
of the atrioventricular(AV) node, AV bundle, and left/right bundle branches which
contributes to the arrhythmia as well as a marked decrease in pacemaker cells in the
sinoatrial(SA) node with advanced aging[26]. Finally, aged population also demonstrates
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degenerative valvular processes which commonly appear in both the aortic and mitral
valves[30]. Although it is well described that these changes happen in most aged
individuals, the mechanisms of these alterations at the molecular level are not elucidated.
Age associated cardiovascular alteration studies using human subjects exist(e.g.
the Baltimore Longitudinal Study on Aging)[31], however, human aging studies are
challenging because of the limitation of non-invasive procedure, setting a cross sectional
design, and controlling confounding variable limit availability. Because these limitations
are relatively controllable in animal studies, cellular and molecular mechanisms that
emphasize age associated cardiovascular changes can be examined. For instance, age
related decline in force production and motility activity that may be the result of
oxidative damages are present in aged Fischer 344(F344) rats muscle[32, 33].
Additionally, age dependent increase in 3-nitrotyrosine content in F344 skeletal muscles
are increased in proteins involved in metabolism and calcium homeostasis such as
sarcoplasmic reticulum Ca(+2)-ATPase, aconitase, beta-enolase, triosephosphate
isomerase, and carbonic anhydrase III[34].
Although F344 rat model are frequently used for aging studies, the hybrid of
F344/NXBN model exhibits significantly fewer pathological conditions, and a greater
mean age of 50 % of mortality[35]. Therefore, this hybrid model is recommended by the
National Institutes on Aging for aging studies. Recently a study demonstrated the
reference values for cardiac structure and function in the aging F344/NXBN rat
model[36]. Similar to humans, these age-associated changes included increases in left
ventricular mass, left ventricular mass/body weight ratio, posterior wall thickness/body
weight ratio, anterior thickness/body weight ratio, and left ventricular chamber
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diameter/body weight ratio. Taken together, these data suggest the aging F344/NXBN rat
model exhibits cardiac alterations with aging very similar to what is seen in humans.
In the conclusion, aging seems to be a major risk of cardiovascular disease. A
tremendous amount of studies have described alteration in the cardiovascular structure
and function with aging, nevertheless, the mechanisms behind the alteration remains
undetermined. Although applications of the result from animal studies are limited, similar
age associated physiological alterations reveal great potential for future applications to
human physiology.

Reactive Oxygen Species (ROS)
A chemical process wherein a substance gains an electron is defined as reduction,
whereas the opposite process of losing an electron is classified as oxidation. Biologically,
the compound that acts as a reducing agent is termed an antioxidant, on the other hand,
the compound that acts as an oxidant is referred to as a pro-oxidant[37]. ROS prooxidants can be classified into two subcategories which include radical and nonradical
types. A radical is a species with an odd number of electrons in the shells such as
superoxide radical (O•-), nitric oxide radical (NO•), hydroxyl radical (OH•-), peroxyl
(ROO•-) and alkoxyl (RO•-) radicals[37]. Typically, these species possess very reactive
characteristics due to the presence of an unpaired electron in the shell. Nonradical species
do not contain an unpaired electron such as hypochlorous acid (HClO), hydrogen
peroxide (H2O2), Ozone (O3) and so on. Nevertheless, some of them are extremely
reactive.
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ROS are known to come from two major categories including endogenous and
exogenous sources. The exogenous factors include γ-, UV-irradiation, ultrasound, food,
drugs, pollutants, Xenobiotics and toxins while endogenous factors are comprised of
neutrophils, enzymes, and mitochondria[37]. Within these potential sources of ROS, it is
thought that increased NAD(P)H oxidase or alterations in mitochondrial function may be
the central cause of enhanced ROS generation in the aged heart[38]. Although there are
many approaches to evaluate the existence of ROS in biochemical reactions, the only
direct ways to measure ROS are electron spin resonance that measures relatively stable
radicals, and the spin trapping method[37]. However, due to the difficulty of direct ROS
detection, the quantification of oxidative damage markers known as the fingerprint
method is often utilized. As an example of the introduction of carbonyl group is often
used as an indices of ROS level [39, 40]. Additionally, when excessive superoxide and
nitric oxide are present, it can produce highly reactive peroxynitrite that can disturb
homeostatic regulation by interacting with macromolecules.[37] Therefore, measuring 3nitrotyrosine is often employed to indicate the nitration of tyrosine residue caused by
nitorosative stress[41]. Generally, the end products of the macromolecules that interact
with ROS indicate the existence of ROS.

Aging and ROS
The wish to be young and healthy is common to all, but morphological and
functional alterations are inevitably exhibited as one ages. It is obvious, but no one can
avoid death. Therefore, the goal of aging research is to understand the mechanism of the
decline of physical function that appears with aging and, hopefully, to delay its progress.
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In gerontology, many theories have been proposed to explain the diversity of the aging
process in nature. Generally speaking, theories of aging are categorized into two major
groups that are composed of several subdivisions. One of the major theories is the
programmed theory that explains aging is regulated by the genes based on a biological
timetable[42, 43]. Another is error or damage theory that focuses on environmental
assaults to the system[8]. Although those two theories contain further branches of
theories, many of these theories are not mutually exclusive[44].
ROS may be an important initiator and mediator of a variety of chronic conditions
such as cancers, neuromuscular dysfunctions, pulmonary disorders and cardiovascular
diseases[45-48]. Similarly, the free radical theory of aging explains that the progression
of aging happens at the biochemical level [49]. Both decreased antioxidant activities, and
increased ROS production may lead to an accumulation of free radicals that cause
oxidation of proteins, nucleic acids, and lipids[39]. In the last third of lifespan,
tremendous increases in the modification of side chain proteins, known as carbonyl
content, has been shown from tissue in a variety of species[40]. Additionally, one third of
these modified proteins are likely to be dysfunctional enzymes or structural proteins.
Although the exact role of ROS still remains to be elucidated, growing evidence
suggests that ROS may play a crucial role in multiple cell signal transductions[50].
Indeed, the cell posses a system to detect and correct alterations from variety of stressors,
including oxidative stress. Nevertheless, if proteins experience excessive ROS, protein
degradation and fragmentation may result which will eventually lead to physiological
changes.
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ROS and cardiovascular disease
Smooth muscle cells proliferation and hypertrophy are due, at least in part, to the
increased ROS that may regulate mitogenesis and apoptosis in vascular smooth muscle
and endothelial cells[51]. It is known that ROS mediated MAPK activation is involved in
smooth muscle cell hypertrophy and inhibition of MAPK by antioxidants may affect
signal transduction[52]. A recent study suggests that vascular aging in the F344/NXBN
rat is associated with an increase in superoxide which is highly correlated with changes in
aortic morphology, total protein nitration and changes in the expression and/or regulation
of proteins involved in metabolic (AMPK-α), signaling (mitogen activated protein
kinases along with c-Src), apoptotic (Bax, Bcl-2, Traf-2), and transcriptional (NF-κB)
activities[19]. These data suggest that age associated alterations such as morphology and
signal transduction in smooth muscle are related to ROS.
In cardiac muscle, cardiomyocyte hypertrophy may be caused by angiotensin II
through the ROS mediated activation of AP-1[53]. Additionally, rat myocytes exposed to
different concentrations of H2O2 regulate hypertrophy and apoptosis by activating
specific proteins including JNK, ERK1/2, p38 and Akt[54]. Moreover, peroxynitrite
seems to activate all the members of MAPK, JNK, ERK, and p38 in H9C2
cardiomyocytes [55]. Taken together, MAPK seems to play a crucial role in ROS
mediated signal transduction in cardiovascular diseases.[56]
A study indicated an age associated decline in HSP70 response against thermal
stress in F344 cardiac muscle[57]. Although this study did not statistically compare the
basal content of HSP 70, aged cardiac muscle revealed higher HSP 70 content than
younger ones. Additionally, ischemic injury in cardiomyocytes seems to be alleviated by
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the over expression of HSP 27[58]. Together, these data suggest aging is associated with
an alteration in HSP expression in the cardiac muscle.
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Abstract
Here we report the influence of aging on multiple markers of oxidativenitrosative stress in the heart of adult (6-month), aged (30-month) and very aged (36month) Fischer 344/NNiaHSd X Brown Norway/BiNia (F344/NXBN) rats. Compared to
6 month old rat hearts, indices of oxidative (superoxide anion (–O2·), 4-hyrdoxy-2nonenal (4-HNE)) and nitrosative (protein nitrotyrosylation) stress were 34.1 ± 28.1%,
186 ± 28.1% and 94 ± 5.8% higher, respectively, in 36-month hearts and these findings
were highly correlated with increases in left ventricular wall thickness (r>0.669; r>0.710
and p<0.01, respectively). Regression analysis showed that increases in cardiac
oxidative-nitrosative stress with aging were significantly correlated with changes in the
expression and/or regulation of proteins involved in transcriptional (NF-κB) activities,
signaling (mitogen activated protein kinases along with Src), apoptotic ( Bcl-2, Traf-2),
and cellular stress (HSPs). These results suggest that the aging F344/NXBN heart may
be highly suited for unraveling the molecular events that lead to age-associated
alterations in cardiac oxidative stress.

(157 words)

Key words: aging; heart; oxidative-nitrosative stress; cell signaling
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Introduction
Aging is thought to be the major risk factor for the development of cardiovascular
disease [59]and is associated with alterations in cardiac morphology, signaling, and
contractile function [60, 61]. Even in the absence of disease, aging in the heart is
characterized by cardiomyocyte loss, left ventricular hypertrophy, changes in ventricular
volume, decreases in fractional shortening and reduced cardiac output [36, 62, 63].
Although there is no clear consensus on what causes aging or age-related changes in
cardiac morphology and function, age-associated increases in oxidative-nitrosative stress
have been posited as being involved [64]. In addition to their potential role in aging, the
study of oxidative-nitrosative stress may be important as they seem to play a role in
cardiac injury, cell death, dysrhythmia and in chronic cardiovascular diseases [18]. It is
thought that oxidative-nitrosative stress exert their influence, in large part, by causing the
gradual accumulation of free radical damage to biomolecules [7]. Recent reports have
supported this hypothesis with data suggesting that aging is associated with alterations in
the oxidative/nitrosative stress biomarkers H2O2, 3-nitrotyrosine (3-NT), N- -methyllysine, malondialaldehyde, and advanced glycation end products [65, 66]. The effects of
pharmacological treatments and exercise on oxidative stress are under investigation [67].
However, the relation between biomarkers of oxidative-nitrosative stress and alterations
in tissue structure and function with aging has not been fully examined [68].
In an attempt to gain greater physiological insight into effects of oxidative stress,
the possible effects of oxidative-nitrosative stress on the content and phosphorylation
status of various cellular proteins is recently being examined. We and others have
demonstrated that aging in the Fischer 344/NNiaHSd X Brown Norway/BiNia
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(F344/NXBN) rat model is characterized by changes in cardiovascular morphology and
function along with increases in vascular reactive oxygen species (ROS) [36, 69, 70].
Specifically, recent studies suggest that vascular aging in the F344/NXBN is associated
with an increase in superoxide anion (–O2·), which is highly correlated with changes in
aortic morphology, total protein nitration and changes in the expression and/or regulation
of proteins involved in metabolic (AMPK-α), signaling (mitogen activated protein
kinases along with c-Src), apoptotic (Bax, Bcl-2, Traf-2), and transcriptional (NF-κB)
activities [70]. A better understanding of possible relationships between oxidativenitrosative stress and the aging F344/NXBN heart may help identify common markers of
oxidative-nitrosative stress between different tissue and muscle types (cardiac versus
smooth) in the aging cardiovascular system.
The purpose of this study was to determine how aging affects multiple, previously
identified markers of oxidative-nitrosative stress in the rat heart. We hypothesized that
aging would be associated with increases in the cardiac content or basal phosphorylation
of oxidative-nitrosative stress markers. Similar to our previous study examining the
aging vasculature, the analyses of oxidative-nitrosative stress markers was performed in
hearts from young (6 mo), aged (30 mo), and very aged (36 mo) F344/NXBN rats. Our
data suggest that aging in the F344/NXBN heart is associated with increases in oxidativenitrosative stress, and this alteration is strongly correlated with alterations in cardiac
morphology and oxidative-nitrosative stress indices.
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Results
Left ventricular wall thickness along with markers of ROS and nitrosative
stress are increased with aging
As previously reported, body mass increased with age, while systolic blood pressure was
not significantly altered [70]. Phosphotungstic Acid-hematoxylin, Malloy’s (PTAH)
staining of cross sections of cardiac tissues demonstrated evidence of age associated
pathology, including increased fibrosis and sarcolemmal ulceration (Fig. 1). Compared
to the 6 month old animals, left ventricular wall thickness was 59.0 ± 12.7% and 26.3 ±
13.8% higher in the 30- and 36-months, respectively (P<0.01). Ethidium fluorescence
was seen throughout the cardiac cross section (Fig. 2, A). Quantification of (–O2·) as
determined by oxidation of hydroethidine (HE) to ethidium bromide (Et) and the
quantification of Et fluorescence by semiquantitative analysis was 54.2 ± 20.4% and 34.1
± 28.1% higher in 30- and 36-month cardiac preparations compared to the levels
determined in 6-month hearts (Fig. 2, B) (P<0.01). In order to further examine how
aging may influences ROS production we also examined protein isolates for the presence
of proteins modified by the lipid peroxidation metabolite 4-hydroxy-2-noneanl (4HNE)[71, 72]. Compared to hearts obtained from 6- month animals, 4-HNE levels as
determined by immunoblotting were 79 .2 ± 4.4% and 94.0 ± 5.8% higher in the 30- and
36-month heart, respectively (Fig. 3) (P<0.01).
Superoxide has been shown to react with nitric oxide to form reactive nitrogen
species, specifically, peroxynitrite is able to modify proteins by interacting with tyrosine
residues to form 3-nitrotyrosine [73]. Compared to hearts obtained from 6-month
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animals, tyrosine nitration, a marker of nitrosative stress, was 152.2 ± 4.2% and 168.6 ±
5.2% higher in the 30- and 36-month heart, respectively (P<0.01) (Fig. 4, Table 1). To
examine whether these increases in tyrosine nitration were associated with the cardiac
myocyte, immunohistochemical analysis was performed. Consistent with our
immunoblotting experiments, with aging we observed an increase in the amount of
immunoreactive nitro-Tyrosine signal throughout the myocardium of the aging heart that
appeared to be localized primary within the myocyte (Fig. 4 B-D). Taken together these
data suggest that increased nitrosative stress may participate in age-related cardiac
protein modification.

Phosphorylation of the metabolic sensor protein AMPK-α is unaltered with
aging
AMPK is a metabolite-sensing protein that senses nutritional and environmental stresses
and acts as a metabolic master switch [74]. To determine whether aging influenced the
regulation of AMPK-α in the heart, gel electrophoresis and immunoblot analysis using
antibodies that recognize both the unphosphorylated and phosphorylated form of AMPKα was performed. Compared to hearts obtained from 6- month animals, AMPK-α content
was unchanged with aging (Fig. 5, Table 1). Given that AMPK-α is activated by
phosphorylation, it was important to establish if aging in the heart was characterized by
changes in the basal phosphorylation level of the threonine 172 residue, a necessary and
sufficient step for AMPK-α activation and thus an established marker for AMPK-α
activity. Compared to the 6-month heart, the basal phosphorylation of AMPK-α (Thr
172) showed no significant change in the 30- or 36-month hearts (Fig. 5, Table 1).
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The cardiac content and basal phosphorylation of the signaling molecules Src,
p44-p42 (ERK 1/2)-, p38- and JNK-MAPK are altered with aging
The Src and MAPK proteins play a key role in propagating external stimuli into the
cytoplasm and nucleus [75]. Compared to hearts obtained from 6-month animals, JNK-1
and JNK-3 content was 19.1 ± 9.1%, and 14.7 ± 4.4% higher in the 30-month heart, while
JNK-2 levels were not different. In the 36-month heart, the JNK-1, JNK-2, and JNK-3
content was 37.9 ± 6.7%, 30.6 ± 7.0%, and 24.4 ± 2.9% higher, respectively (P<0.01)
(Fig. 5, Table 1). Compared to hearts obtained from 6-month animals, p38α content was
higher in both the 30- (54.3 ± 7.3%) and 36-month (42.0 ± 8.9%) heart (P<0.01) (Fig. 5,
Table 1). The amount of p44 (ERK1) and p42 (ERK2) was unchanged with aging (Fig.
5, Table 1). Compared to 6-month heart, the basal phosphorylation of JNK-1 and JNK-3
(Thr 183/Tyr 185)-MAPK was 72.1 ± 15.8% and 25.7 ± 8.6% higher in the 30-month
heart and 47.0 ± 14.5% and 24.5 ± 10.0% higher in the 36-month heart, respectively,
(P<0.01) (Fig. 6, Table 1). Similarly, the basal phosphorylation of JNK-2 (Thr 183/Tyr
185) MAPK was 57.0 ± 9.4% and 31.7 ± 11.5% lower in the 30- and 36-month heart
respectively (P<0.01) (Fig. 6, Table 1). The phosphorylation of p38α (Thr180/ Tyr182)
was 32.2 ± 7.3% higher in the 30-month hearts and 17.5 ± 4.6% lower in the 36-month
heart, as compared to the hearts obtained from the 6-month animals (P<0.01) (Fig. 6,
Table 1). Compared to 6-month heart, the basal phosphorylation of p44 (ERK1) and p42
(ERK2) (Thr 202/Tyr 204)-MAPK was 108.5 ± 23.5% and 98.7 ± 9.0% higher in the 30month heart and 49.1 ± 26.5% and 46.8 ± 7.8% higher in the 36-month heart,
respectively, (P<0.01) (Fig. 6, Table 1). Conversely, with aging the amount of Src was
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17.9 ± 6.2 and 20.2 ± 7.8% lower in the 30- and 36-month heart compared to the 6-month
heart, respectively (P<0.01) (Fig. 6, Table 1). The phosphorylation of the active form of
Src (Tyr 527) was 44.5 ± 12.8% higher in the 30- month heart, compared to the 6-month
heart (P<0.01) (Fig. 6, Table 1). However in the 36-month heart the phosphorylation of
Src (Tyr 527) failed to demonstrate a significant change compared to the 6-month heart
(Fig.6, Table 1).

Aging altered the cardiac content of the apoptotic regulators Bax, Bcl-2, and
Traf-2
Bax, Bcl-2, and Traf-2 are key regulators of apoptosis [76]. With aging, Bax showed no
significant change at 30-month; however Bax expression was higher in the 36-month
heart 21.9 ± 7.4% compared to the 6-month age group. Similarly, Bcl-2 content was 97.6
± 9.8% and 27.5 ± 8.4% (P<0.01) higher in the 30- and 36-month age groups,
respectively (Fig. 7, Table 1). On the other hand, Traf-2 was 13.6 ± 6.1% and 7.8 ± 6.8%
lower in the 30- and 36-month aged heart, respectively (P<0.01) (Fig. 7, Table 1).

Aging increases cardiac HSP27 and HSP70
Exposure to cellular stress is thought to increase the cellular content of the heat shock
proteins (HSPs) [77] Compared to hearts obtained from 6-month animals, HSP27 content
was 76.6 ± 14.0% and 82.5 ± 17.4% higher in the 30- and 36-month hearts, respectively
(P<0.01) (Fig. 7, Table 1). Similarly, the content of HSP70 in the heart was 47.5 ±
10.4% and 90.2 ± 7.4% higher in the 30- and 36-month hearts (P<0.01) (Fig. 7, Table 1).
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Aging alters the expression of the transcription protein NF-κB
NF-κB is a transcription factor that has been implicated in the control of inflammatory
responses, cellular growth, and apoptosis [78]. Compared to the hearts obtained from 6month animals, NF-κB p65 content was 96.1 ± 16.7% higher and 118.0 ± 8.5% higher in
the 30- and 36-month heart, respectively (P<0.01). Similarly, NF-κB p50 content was
66.2 ± 7.5% and 55.7 ± 6.2% higher in the 30- and 36-month heart, respectively (P<0.01)
(Fig. 7, Table 1). Conversely, with advanced aging the phosphorylated levels of NF-κB
p65 in the 30-month and 36-month heart were unchanged compared to the 6-month levels
(Fig. 7, Table 1).
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Discussion
There is emerging evidence suggesting that age-related declines in cardiac
function may be associated with age-associated increases in oxidative-nitrosative stress
[79]. Presently, it is unclear how these seemingly disparate phenomena are connected.
Indeed, a causal role of oxidative-nitrosative in the age-dependent decline of cardiac
dysfunction can only be defined if biological targets of these species are identified and
the physiological impact of biomolecular modification is characterized. To this end, we
attempted to investigate the effects of cardiac aging on the regulation of previously
identified markers of oxidative-nitrosative stress. We demonstrate that aging in the
F344/NXBN heart is strongly correlated with, and characterized by elevations in cardiac
markers of oxdiatvie- nitrosative stress. The increase in these markers of are in turn
significantly correlated with age-associated increases in ventricular thickness along with
changes in the expression and /or regulation of proteins involved in intracellular signaling
(MAPKs along with c-Src), apoptotic (Bax, Bcl-2, Traf-2), heat shock (HSP 27, HSP70)
and transcriptional (NF-κB) activities. Although not capable of proving cause and effect,
these data, taken together, suggest that age-associated changes in oxidative-nitrosative
stress are related to changes in cardiac morphology and multiple signaling pathways
which influence cell function.
Similar to previous reports, utilizing the F344/NXBN[62] and Fischer rat models
[80] we show an age-related increase in left ventricular thickness. Further, we observed
an increase in Et fluorescence and 4HNE levels with aging in the F344/NXBN heart
suggesting increased (–O2·) levels. These findings are consistent with earlier data which
have suggested that aging is associated with increases in cardiac ROS [81, 82].Using
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statistical analysis we demonstrate a high correlation between age-associated increases in
ventricular wall thickness and elevations in ventricular (–O2·) levels as determined by HE
staining (Fig. 2). This possibility is supported by recent reports suggesting a link
between increases in intracellular ROS and cardiomycyte hypertrophy[83] [53, 84, 85].
The possible source of increased ROS in the aging myocardium are not fully elucidated
but could include xanthine and NAD(P)H oxidoreductases, cyclooxygenase, activated
neutrophils and mitochondrial dysfunction among many others [86-88]. Of these,
alterations in mitochondrial function may be particularly attractive, Indeed, it is widely
accepted that aging impairs mitochondria function and that this impairment is often
associated with increased formation of ROS [89]. How increased age may cause
alterations in mitochondria function and structure or the accumulation of dysfunctional
mitochondria is not well understood. With respect to the latter possibility, Terman and
colleagues have suggested that age-related increases in the number of lipofuscin-loaded
lysosomes may cause decreased mitochondrial turnover and favor the accumulation of
damaged mitochondria [90-92]. Together, these data suggest that the increased (–O2·) in
the ventricular wall of aged F344/NXBN rats may contribute to age-associated
ventricular wall thickening and accumulation of lipofuscin. Whether age-related
alterations in mitochondrial function or some other mechanism is responsible for the
increased oxidative stress we see in the aging F344/NXBN heart is currently being
investigated.
Similar to ROS, the excessive production of nitric oxide (NO) by nitric oxide
synthases which can lead to the generation of the powerful oxidant peroxynitrite have
also been implicated in the pathogenesis of cardiovascular dysfunction [93].
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Peroxynitrite, in turn, is thought to cause the protein nitration and the quantification of
this latter process is a well established marker for reactive nitrogen species production
[94]. In the present study, our data showing an increase in protein tyrosine nitrosylation
are consistent with the notion that aging increases peroxynitrite formation (Figure 4).
Although the physiological effects of protein nitration are not entirely elucidated,
previous studies have suggested that nitration can alter protein function and
conformation, impose steric restrictions, and also inhibit tyrosine phosphorylation [95].
Similar findings of increased protein nitration have recently been reported in the aging
F344/NXBN heart [96] In this study, Kanski and co-workers using one- and twodimensional western blotting coupled with nanoelectrospray ionization-tandem mass
spectrometry identified a number of proteins that may have suffered protein nitration as a
consequence of biological aging. In particular, these researchers demonstreated that
aging may be associated with the nitration of cytochrome C oxidase (~19 kDa), ATPase
(~28 kDa), GAPDH (~38 kDa), and NADH ubiquinone oxireductase (~75 kDa).
Qualitative inspection of our Nitro-Tryrosine immunoblotting experiments suggests the
presence of immunoreactive bands around these molecular weights (Figure 3). Whether
the proteins identified in our analysis are the same as those identified by Kanski and
colleagues is unknown and will necessitate further experimentation.
Increased nitrosative stress may also be involved in regulating the
phosphorylation state of MAPK proteins. For example, recent data has suggested that
peroxynitrite may induce ERK1/2, p38, and JNK phosphorylation
in cultured H9C2 cardiomyocytes[55]. Using protein isolates from aged cardiac samples,
our data suggests that a similar relationship (r > 0.6) may exist in the intact aging rat heart
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(Table 2). Whether alterations in MAPK phosphorylation are due to nitrosative stress or
some other mechanism will require further experimentation. In addition to its effects on
protein structure and function, excessive nitrosative stress may cause severe DNA
damage, activation of poly(ADP-ribose) polymerase(PARP) and the depletion of NAD+
and ATP[97]. Allowed to proceed unchecked, the end result of these latter processes is
often cell death[98]. Our findings of a correlation between level of nitrotyrosine
modification with aging and the cardiac content of the apoptotic regulators, Bax and Bcl2 are consistent with this possibility.
The mechanism(s) by which oxidative-nitrosative stress may exert hypertrophic
effects on cardiomyocytes is not fully understood. Furthermore, how aging may affect
cardiac intracellular signaling processes has not been clearly defined. Thus far, research
examining these questions has been performed, in large part, utilizing cell culture models.
Using intact hearts, we demonstrate that alterations in the regulation of JNK-MAPK,
ERK1/2-MAPK, HSP27, nitrotyrosine, 4-HNE, and NF-ĸB p50 were strongly correlated
(r > 0.70) with aging along with increases in F344/N X BN left ventricular thickness
(Tables 1, 2). Taken together, these data suggest that these molecules may be particularly
involved in mediating the age-associated remodeling of the F344/NXBN heart. To our
knowledge these findings have not been reported before. Nonetheless, these results are in
agreement with previous reports suggesting that these proteins may play a role in cardiac
remodeling [99-104]. Of particular interest are our findings that the phosphorylation
(activation) of the JNK- and ERK-MAPK proteins appears to be regulated differently
with aging. For example, whereas the JNK 1, JNK 2, and ERK-2 (p42) isoforms are
strongly correlated with aging and ventricular hypertrophy, JNK 3 or ERK 1 is not (Table
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2). Although the function of the different JNK or ERK1/2 MAPK isoforms is not fully
understood, recent reports have begun to shed light on this area of research. For example,
recent studies by Tachibana and colleagues [105] along with Kaiser and associates [106]
have suggested that JNK1 and JNK2 play a protective role in cardiac myocytes by
functioning to prevent cardiac inflammation and apoptosis. The cardioprotective effects
of transforming growth factor-ß1 during ischemia-reperfusion were shown to mediated
via Erk1/2, ERK 2 is also thought to function in a cardioprotective role [107] whereas
others have suggested the involvement of ERK 2 in ROS-mediated cell hypertrophy
[108]. Whether the alterations in JNK 1, JNK 2 and ERK 2 regulation we see with aging
in the F344/NXBN are related to cardioprotective or hypertrophic processes awaits
further clarification.
The heat shock proteins are thought to be induced by stressful stimuli and have
been shown to protect cells and organs from cellular insult [109]. In vitro studies have
demonstrated that HSP 27 acts as a molecular chaperone, as an actin capping-decapping
protein stabilizing the cytoskeleton, and as a defense mechanism against elevated ROS
[110]. What role(s) HSP 27 may play in the aging heart has not been fully defined. With
aging we show a marked increase in HSP 27 protein levels (Figure 9, Table 1). Although
determining the function that HSP 27 may play in the aging F344/NXBN heart is beyond
the scope of the present investigation, previous studies employing ischemic stimuli, a
known stimulator of intracellular ROS, have suggested that HSP27 may play a role in
cardioprotection [111]. We speculate that age-associated increases in HSP 27 may be a
compensatory mechanism to circumvent the augmented ROS we show with aging in the
F344/NXBN heart.
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It has been hypothesized that ROS may contribute to the biology of aging through
NF-ĸB mediated regulation of gene expression [112]. In addition, several recent studies
have revealed a novel relationship between NF-ĸB and JNK-MAPK in which NF-ĸB is
thought to antagonize JNK activation and act to suppress apoptosis [22, 113]. That data
of the present investigation are consistent with this notion. In addition to the possible
role that NF-ĸB may play in regulating cell death, others have reported that NF-ĸB may
be involved in mediating cardiac hypertrophy [114]and even as an antioxidant [115, 116].
Further studies will be needed to discern what role NF-ĸB may play in the aging heart.
In summary, we have found that aging in the F344/NXBN heart is characterized
by increased levels of oxidative- nitrosative stress and alterations in several signal
transduction pathways. Further information on the individual or combined effects of
these changes may reveal their role in aging cardiac morphology and function. Indeed,
there is much remaining to be learned about the signaling cascades involved and the
points at which ROS exert their effects. Due to the similarities between the aging
F344/NXBN and humans [117, 118] our data suggest that the aging F344/NXBN heart
may be highly suited for unraveling the molecular events that lead to age-associated
alterations in cardiac ROS.
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Experimental Procedures
Animals
All procedures were performed as outlined in the Guide for the Care and Use of
Laboratory Animals as approved by the Council of the American Physiological Society
and the Animal Use Review Board of Marshall University. Adult (6 months), aged (30
months) and very aged (36 months) male F344/NXBN rats were obtained from the NIA.
Probability of survival curves generated by the NIA has indicated that rats of these ages
generally represent humans in their third, sixth and eighth decade of life, respectively[35,
118, 119]. Data collected from these animals regarding age associated alterations in aortic
ROS levels have previously been published [70].
Rats were barrier housed individually in an AAALAC approved vivarium.
Housing conditions consisted of a 12H: 12H dark-light cycle and temperature was
maintained at 22° ± 2°C. Animals were provided food and water ad libitum. Rats were
allowed to recover from shipment for at least two weeks before experimentation began.
During this time the animals were carefully observed and weighed weekly to ensure none
exhibited signs of failure to thrive, such as precipitous weight loss, disinterest in the
environment, or unexpected gait alterations. Systolic blood pressure was determined with
the animal unanesthetized using a programmed electrosphygmomanometer with
pneumatic tail cuff (Narco-Biosystems, Houston, TX). Animals were acclimated to the
procedure for a minimum of 3 days prior to obtaining blood pressure.
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Materials
Antibodies against Bax (N-20) [sc-493], Bcl-2 (C-2) [sc-7382], HSP27 (M-20)
[sc-1049], HSP70 (K-20) [sc-1060], NF-κB p50 (E-10) [sc-8414] and Traf-2 (C-20) [sc876], mouse IgG, goat IgG, and rabbit IgG antibodies were purchased from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). Antibodies against AMPK-α [#2532],
p44/42(ERK1/2-MAPK) [#9102], p38-MAPK α [#9218], SAPK/JNK-MAPK [#9252],
NF-κB p65 [#3034], Non-phospho-Src (Tyr527) [#2107], p-AMPK-α (Thr 172) [#2531],
p-p44/42 (Thr 202/ Try 204) [#9106], p-p38 (Thr 180/ Try 182) [#9216], p-SAPK/JNK
(Thr 183/Tyr 185) [#9251], p-NF-κB p65 (Ser536) [#3031], p-Src (Tyr527) [#2105],
Nitro-Tyrosine [#9691], Biotinylated protein ladder, mouse and rabbit IgG antibodies
were purchased from Cell Signaling Technology (Beverly, MA) while anti-4-HNE
(MHN-020P) was from (JaICA, Shizuoka, Japan). The dihydroethidium (hydroethidine)
[HE] was obtained from Molecular Probes (Eugene, OR). Precast 10% SDS-PAGE gels
were procured from Cambrex Biosciences (Baltimore, MD), and enhanced
chemiluminescence (ECL) western blot detection reagent was acquired from Amersham
Biosciences (Piscataway, NJ). Restore western blot stripping buffer was obtained from
Pierce (Rockford, IL) and 3T3 cell lysates were from Santa Cruz Biotechnology (Santa
Cruz, CA). All other chemicals were purchased from Sigma (St. Louis, MO).

Heart Collection
Rats were anesthetized with a ketamine-xylazine (4:1) cocktail (50 mg/kg IP) and
supplemented as necessary for reflexive response. After midline laparotomy, the heart
was removed and placed in Krebs-Ringer bicarbonate buffer (KRB) containing; 118 mM
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NaCl, 4.7 mM KC1, 2.5 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 24.2 mM
NaHCO3, and 10mM α-D-glucose, (pH 7.4) equilibrated with 5% CO2 / 95% O2 and
maintained at 37°C. Isolated hearts were quickly massaged to remove any blood from
the ventricles, cleaned of connective tissue, weighed, and immediately snap frozen in
liquid nitrogen.

Histology and Oxidative Fluorescent Microscopy
Heart specimens were serially sectioned (8 μm) using an IEC Minotome cryostat
and collected on poly-lysine coated slides. After fixing in acetone, (-20°C for 2 min)
sections were stained with hematoxylin and eosin, mounted and cover slipped.
Morphometric evaluation was performed with the use of a computerized imaging analysis
system (Olympus MicroSuite™ Basic). Ventricular and septal wall thickness in μm was
calculated from the average of eight different points of cross section. Phosphotungstic
Acid-hematoxylin, Malloy’s (PTAH) staining of serially sectioned cardiac tissue was
performed according to the manufactures guidelines (poly Scientific R & D Corp., Bay
Shore, NY).
Hydroethidine (HE), an oxidative fluorescent dye, was used to visualize
superoxide production in situ [120, 121]. HE freely permeates the cells and in the
presence of (–O2·) is oxidized to ethidium bromide (Et), where it is trapped by
intercalating with the DNA [122]. Because Et is impermeable to cell membranes,
extracellular (–O2·) would not be expected to significantly contribute to the observed
cellular fluorescence. Neither hydroxyl radical, ·NO, peroxynitrite, H2O2, hypochlorite,
nor singlet O2 significantly oxidizes HE, as such, an increase in Et fluorescence is thought
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to specifically indicate (–O2·) generation within the fluorescing cell. Heart sections were
stained with HE and visualized under fluorescence as described previously [70]. The
intensity of fluorescent Et–stained nuclei was calculated by digitizing images and then
determining the average pixel intensity of six randomly positioned regions (1000 µm2)
per arterial cross section. Eight images per vessel were analyzed with ≥ 500 nuclei per
vessel examined.

Immunohistochemistry
Immunostaining for Nitro-Tyrosine was visualized by immunofluorescence as
outlined by the antibody manufacturer. Briefly, sections were washed three times with
phosphate buffered saline (PBS) containing 0.5% Tween 20 (PBS-T), pH 7.5. After
incubation for 30 min in a blocking solution (5% BSA) sections were incubated with
specific antisera diluted in PSB-T (antibody dilution of 1:100) for 1 hr at 24° C in a
humidified chamber. After washing three times in PBS, sections were incubated with
FITC anti-rabbit IgG (1:200) for 30 min at 24° C in a humidified chamber. DAPI was
also included in the secondary antibody solution at a concentration of 1.5 μg /ml in order
to visualize cell nuclei. After a final PBS wash and mounting specimens were visualized
by epifluorescence using an Olympus fluorescence microscope (Melville, NY) fitted with
a 40X objective. Images were recorded digitally using a CCD camera and analyzed using
Olympus MicroSuite™ Basic from Olympus America (Melville, NY).

31

Immunoblot Analysis
Tissues were pulverized in liquid nitrogen using a mortar and pestle until a fine
powder was obtained and washed three times with ice cold PBS as described previously
[123]. Samples were then suspended on ice in 100 μl of TPER (2 mL/1g tissue weight)
(Pierce, Rockford, IL) supplemented with 100 mM NaF, 1 mM Na3VO4, 2mM PMSF, 1
μg/ml aprotinin, 1 μg/ml leupeptin, and 1 μg/ml pepsatin. After lysis, homogenates were
centrifuged 10 min at 13,000 g and the supernatant collected.
Protein concentrations of homogenates were determined in triplicate via the
Bradford method (Pierce) using bovine serum albumin as a standard. Samples were
diluted to a concentration of 3 mg/ml in SDS-loading buffer and boiled for 5 minutes.
Sixty μg of total protein for each sample was separated on a 10% SDS-PAGE gel.
Transfer of protein onto nitrocellulose membranes was performed using standard
conditions. To verify transfer of proteins and equal loading of lanes the membranes were
stained with Ponceau S. Semiquantitiative immunodetection of specific proteins was
performed using established methods as described previously [70]. A total of three SDSPAGE gels were run for each experimental set to evaluate changes in dependent variable
tissue content and basal phosphorylation where applicable. Immunoblots were stripped
with Restore western blot stripping buffer as described by the manufacturer to obtain
direct comparisons between expression and phosphorylation levels of different signaling
molecules. After verifying the absence of residual HRP activity by reacting the
membrane with the ECL reagent, membranes were washed and reprobed. Randomization
of antibody incubation was utilized to minimize potential experimental error associated
with membrane stripping.
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Data Analysis
Results are presented as mean ± SEM. Data were analyzed by using the
SigmaStat 3.0 statistical program. A one-way analysis of variance (ANOVA) was
performed for overall comparisons with the Student-Newman-Keuls post hoc test used to
determine differences between groups. Regression analysis of the dependent variables
was performed across age groups using values from four individual hearts from each
group. Significance of correlation was analyzed by one-way ANOVA. The level of
significance accepted a priori was ≤ 0.01.
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Chapter 4
Conclusions and Future Directions
Conclusions
1. Aging significantly affects the presence of ROS in the F344/NXBN heart. The
increased ROS are significantly correlated with age-associated increases in
ventricular wall thickness.

2. Aging significantly alters the expression and phosphorylation of proteins
associated with cell signaling, apoptotic, heat shock and transcription activities in
the F344/NXBN heart.

3. Age-associated increases in ROS are strongly correlated with multiple previously
identified markers of oxidative stress (MAPK, Src, Bax, Bcl-2, NF-κB, and HSP)
in the rat heart.
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Future Directions
Future directions for research based on this study should focus on the mechanism
of ROS mediated signal transduction in the aged cardiac muscle as well as the effect of
pharmacological and / or exercise on ROS levels and signaling. Indeed, the importance of
ROS on the aging process has been emphasized for a half century. Today, this aging issue
seems to become much more serious concern than ever before because a huge baby boom
population will be categorized as aged population. A better understanding of the
mechanisms involved in ROS mediated cell signal transduction may support
implementing an anti-aging approach. Currently, aging and mitochondria dysfunction are
under investigation. It is conceivable that this potential ROS generating organelle may
play a crucial role in the process of aging. Future studies designed to determine how
aging may affect mitochondrial structure, function and ROS generation may be
invaluable to furthering our understanding of the potential sources of age-associated ROS
generation.
Additionally, studies related to ROS scavengers such as anti-oxidants may
provide a treatment for accumulation or overproduction of ROS, in much the same way
that drugs produced to treat and cure one illness are found to be quite effective in treating
one another. Studies designed to investigate the effects of anti-oxidants on cardiac ROS
with aging may elucidate new treatments that could be recommended for the prevention
of age-associated cardiovascular disease. Future research will no doubt add to our
understanding and if successful may be useful for decreasing the incidence of
cardiovascular dysfunction in the aging population.
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Appendix
Appendix A
Table 1. Tissue concentration and basal levels of protein phosphorylation in heart
excised from young adult (6 month), aged (30 month), and very aged (36 month) Fischer
344/NNiaHSd X Brown Norway/BiNia F1 hybrid rats. Data was obtained from
immunoblotting analysis using antibodies that recognize the unphosphorylated or
phosphorylated forms of the proteins. Data are presented as percentages of the young
adult value ± SE. The results reflect the analysis of combined protein comparisons of
four individual hearts from each age group. An asterisk (*) designates significant
differences from 6-month age group (p < 0.001).

Table 2.

Regression analysis of the relationship between expression levels of specific

proteins and age, HE staining intensity, protein nitro-tyrosine levels, 4-HNE levels and
left ventricular thickness of hearts obtained young adult (6 month), aged (30 month), and
very aged (36 month) Fischer 344/NNiaHSd X Brown Norway/BiNia F1 hybrid rats.
The results reflect the analysis of combined proteins and thickness comparisons of four
individual hearts from each age group. An asterisk (*) indicates low correlation between
parameters (p < 0.05), (†) indicates moderate correlation (p < 0.05), (††) indicates high
correlation (p < 0.05), (†††) indicates very high correlation (p < 0.05). N.T. (not tested).
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Table 1
6 Month

30 Month

36 Month

100.0 ± 1.5
100.0 ± 3.5

+ 101.8 ± 2.4
- 9.0 ± 5.8

+ 101.7 ± 3.4
+ 110.0 ± 4.5

100.0 ±
100.0 ±
100.0 ±
100.0 ±
100.0 ±
100.0 ±
100.0 ±
100.0 ±
100.0 ±
100.0 ±
100.0 ±
100.0 ±
100.0 ±
100.0 ±

+
+
+
+
+
+
+
+
+
+
+
+

5.4*
2.4
2.2*
9.7*
3.4*
4.2*
4.1*
4.8*
2.2
1.4
3.7*
6.9*
3.0*
3.7*

+
+
+
+
+
+
+
+
+
+
-

100.0 ± 4.2
100.0 ± 5.0
100.0 ± 5.5

+ 104.6 ± 6.4
+ 197.6 ± 4.8*
- 13.6 ± 0.6

+
+
-

121.9 ± 3.2*
127.5 ± 3.4*
7.8 ± 1.3

100.0 ± 8.7
100.0 ± 4.3

+ 176.6 ± 5.3*
+ 147.5 ± 6.1*

+
+

182.5 ± 8.7*
190.2 ± 3.1*

100.0 ± 1.9
100.0 ± 4.3

+ 252.2 ± 2.3*
+ 179.3 ± 4.4*

+
+

268.6 ± 3.3*
194.0 ± 5.8*

100.0 ± 3.0
100.0 ± 7.8
100.0 ± 2.9

+ 166.2 ± 4.5*
+ 196.1 ± 13.8*
6.6 ± 1.7

+
+
+

155.7 ± 3.3*
218.0 ± 5.7*
107.7 ± 5.3

Metabolic
AMPK-α
p-AMPK-α (Thr 172)
Signaling
JNK 1
JNK 2
JNK 3
p-JNK 1 (Thr 183/ Tyr 185)
p-JNK 2 (Thr 183/ Tyr 185)
p-JNK 3 (Thr 183/ Tyr 185)
p38
p-p38 (Thr 180/Tyr 182)
p44
p42
p-p44 (Thr 202/Tyr 204)
p-p42 (Thr 202/Tyr 204)
Src
p-Src (Tyr 527)

3.7
3.7
2.1
6.1
6.0
4.4
2.5
2.5
3.1
1.2
19.8
2.0
3.3
9.1

119.1 ±
108.8 ±
114.7 ±
172.1 ±
57.0 ±
125.7 ±
154.3 ±
132.2 ±
105.6 ±
103.2 ±
208.5 ±
198.7 ±
17.9 ±
144.5 ±

137.9 ±
130.6 ±
124.4 ±
147.0 ±
31.7 ±
124.5 ±
142.0 ±
17.5 ±
102.0 ±
101.4 ±
149.1 ±
146.8 ±
20.2 ±
7.47 ±

3.0*
3.3*
0.8*
8.4*
5.5*
5.6*
5.7*
2.1*
5.4
3.1
6.7*
5.7*
4.6*
8.7

Apoptotic Regulators
Bax
Bcl-2
Traf-2
Heat Shock Proteins
HSP 27
HSP 70
Protein Modification
Nitro-Tyrosine
4-HNE
Transcription Factors
NF-κB p50
NF-κB p65
p-NF-κB p65
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Table 2
Age

HE

4-HNE

NitroTyrosine

Left Ventricular
Thickness

N.T.
0.652†
0.993†††
0.985†††
0.682†

0.652†
N.T.
0.663†
0.661†
0.669†

0.985†††
0.661†
0.981†††
N.T.
0.710††

0.993†††
0.663†
N.T.
0.981†††
0.735††

0.682†
0.669†
0.735††
0.710††
N.T.

0.267
0.183

0.209
0.181

0.240
0.125

0.291
0.143

0.437*
0.240

0.839††
0.762††
0.913†††
0.763††

0.426*
0.376*
0.515†
0.623†

0.798††
0.732††
0.871††
0.766††

0.801††
0.691†
0.881††
0.813††

0.367*
0.223
0.487*
0.742††

0.724††

0.613†

0.746††

0.765††

0.851††

0.774††

0.448*

0.764††
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0.811††
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0.195
0.294
0.613†

0.263
0.342*
0.586†

0.230
0.311*
0.622†

0.195
0.280
0.622†

0.255
0.361*
0.810††

0.708††

0.675†

0.719††

0.762††

0.876††

0.798††
0.082

0.550†
0.255

0.786††
0.098

0.813††
0.178

0.655†
0.546†

0.597†
0.578†
0.467*

0.254
0.579†
0.535†

0.574†
0.589†
0.473*

0.561†
0.649†
0.481*

0.207
0.884††
0.624†

0.927†††
0.928†††

0.564†
0.526†

0.917†††
0.906†††

0.928†††
0.895††

0.727††
0.438*

Independent
Variable
Age
HE
Nitro-Tyrosine
4-HNE
Left Ventricular
Thickness
Metabolic
AMPK-α
p-AMPK-α (Thr 172)
Signaling
JNK 1
JNK 2
JNK 3
p-JNK 1 (Thr 183/
Tyr 185)
p-JNK 2 (Thr 183/
Tyr 185)
p-JNK 3 (Thr 183/
Tyr 185)
p38
p-p38 (Thr 180/Tyr
182)
p44
p42
p-p44 (Thr 202/Tyr
204)
p-p42 (Thr 202/Tyr
204)
Src
p-Src (Tyr 527)
Apoptotic
Regulators
Bax
Bcl-2
Traf-2
Heat Shock Proteins
HSP 27
HSP 70
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Transcription
Factors
NF-κB p50
NF-κB p65
p-NF-κB p65

0.904†††
0.950†††
0.207

0.669†
0.687†
0.118
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0.902†††
0.954†††
0.246

0.931†††
0.942†††
0.159

0.809††
0.684†
0.084

Figure 1. Aging alters cardiac tissue morphology. PTAH staining of 6- and 36 –
month hearts demonstrating age associated change. A and C. Denote 6- month heart
sections displaying typical cardiac striation pattern. Bar indicates 50 or 20 µm. B and D.
Denote 36- month heart sections displaying atypical cardiac striation pattern with fibrous
tissue infiltration. Bar indicates 50 and 20 µm. n = 4 hearts per age group.

Figure 2. Aging increases cardiac ROS. A. Detection of vascular superoxide by
dihydroethidium (hydroethidine) with aging in the heart of 6-, 30- and 36-month
F344/NXBN. The increase in superoxide involves all regions within the ventricular
wall. Bar indicates 20 µm. B. Quantification of cardiac ROS as determined by intensity
of fluorescent Et–stained nuclei. Results are expressed as percent of the 6 month value.
An asterisk (*) indicates significant difference from the young adult (6 month) value, p <
0.01, n = 4 hearts per age group.

Figure 3. Aging increases 4-HNE content in cardiac muscle.
The quantity of 4-HNE modified proteins was measured from young adult (6 month),
aged (30 month), and very aged (36 month) rat hearts. Results are expressed as percent of
the 6 month value. An asterisk (*) indicates significant difference from the young adult (6
month) value, p < 0.01 or less, n = 4 observations per group.

Figure 4. Increasing age in the heart is associated with increases the nitration of
tyrosine residues. Proteins isolated from the heart of young adult (6 month), aged (30
month), and very aged (36 month) rats were analyzed by immunoblotting for age-related
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changes in the extent of protein tyrosine nitration. A. Results are expressed as percent of
the 6 month value. An asterisk (*) indicates significant difference from the young adult
(6 month) value, p < 0.01 or less, n = 4 observations per group. Immunohistologial
staining of 6-, 30-, and 36 – month hearts demonstrating age associated change in NitroTyrosine immunoflorecense. B - D. Denote 6- , 30-, and 36- month heart sections
displaying immunoreactivty specific for nitrosylated proteins.

Figure 5. Aging differentially affects the expression and/or regulation of proteins
involved in AMPK and the concentration of MAPK protein in rat heart. Hearts
from young adult (6 month), aged (30 month), and very aged (36 month) rats were
analyzed by immunoblotting for age-related changes in AMPK and in phosphorylated
AMPK-α (Thr 172), p44 (ERK1), p42 (ERK 2), p38-α, JNK-1, JNK-2, and JNK-3
protein content. Results are expressed as percent of the 6 month value. An asterisk (*)
indicates significant difference from the young adult (6 month) value, p < 0.01 or less, n
= 4 observations per group.

Figure 6. Aging differentially affects the phosphorylation status of the signaling
proteins in the rat heart. Protein extracts obtained from the hearts of young adult (6
month), aged (30 month), and very aged (36 month) rats were analyzed by
immunoblotting for age-related changes in phosphorylated p44 (ERK 1), p42 (ERK 2)
(Thr 202/ Tyr 204) , p38-α (Thr 180/ Tyr 182), JNK-1 (Thr 183/ Tyr 185), JNK-2 (Thr
183/ Tyr 185), JNK-3 (Thr 183/ Tyr 185), Src and p-Src (Tyr527) protein content.
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Results are expressed as percent of the 6 month value. An asterisk (*) indicates
significant difference from the young adult (6 month) value, p < 0.01 or less, n = 4
observations per group.

Figure 7. Aging alters apoptotic, transcriptional and heat shock proteins levels.
Protein isolates from hearts excised from young adult (6 month), aged (30 month), and
very aged (36 month) rats were analyzed by immunoblotting for age-related changes in
Bax, Bcl-2, Traf-2, HSP27, HSP70, NF-κB p65 and NF-κB p50 protein content. Results
are expressed as percent of the 6 month value. An asterisk (*) indicates significant
difference from the young adult (6 month) value, p < 0.01 or greater, n = 4 observations
per group.
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Appendix B
Aging Cytosolic heart
Film Properties Report for AMPK- α
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Gel type: 10% Tris-HCL SDS_PAGE

Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Transfer Voltage: 24V

Duration: 45 min

Primary Antibody Dilution: 1/1000

Primary Antibody: AMPK-α (Cell Signal)
Incubation Time: 1hr @ Room temp

Medium: 5% BSA in TBS-T
Secondary Antibody Dilution:1/1000

Secondary Antibody: Anti-Rabbit
Incubation Time: 1hr@room temp

Medium: 5% milk in TBS-T
Molecular weight: 62 kDa

Exposure Time: 15 seconds
Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
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Aging Cytosolic heart
Film Properties Report for Phospho-AMPK-α
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Duration: 45 min

Primary Antibody: P-AMPK-α (thr172)(Cell Signal)Primary Antibody Dilution: 1/1000
Medium: 5% BSA in TBS-T

Incubation Time: Overnight @ 4°C
Secondary Antibody: Anti-Rabbit

Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: 1 minutes

Molecular weight: 62 kDa

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
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Aging Cytosolic heart
Film Properties Report for SAPK/JNK
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Primary Antibody: SAPK/JNK (Cell Signal)
Incubation Time: 1hr @ Room temp
Secondary Antibody: Anti-Rabbit

Duration: 45 min

Primary Antibody Dilution: 1/1000
Medium: 5% BSA in TBS-T
Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: 15 seconds

Molecular weight: 46, 49, 54 kDa

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
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Aging Cytosolic heart
Film Properties Report for Phospho-SAPK/JNK
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Primary Antibody: P- SAPK/JNK (Cell Signal)

Duration: 45 min

Primary Antibody Dilution: 1/1000
Medium: 5% BSA in TBS-T

Incubation Time: Overnight @ 4°C
Secondary Antibody: Anti-Rabbit

Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: 1 minutes

Molecular weight: 46,49,54 kDa

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
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Aging Cytosolic heart
Film Properties Report for P38 MAP Kinase
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Duration: 45 min

Primary Antibody: P38 MAP Kinase (Cell Signal) Primary Antibody Dilution: 1/1000
Medium: 5% BSA in TBS-T

Incubation Time: Overnight @ 4°C
Secondary Antibody: Anti-Rabbit

Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: 5seconds

Molecular weight: 40 kDa

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
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Aging Cytosolic heart
Film Properties Report for Phospho-P38(Thr180/Tyr182)
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Duration: 45 min

Primary Antibody: P- P38(Thr180/182)(Cell Signal)Primary Antibody Dilution: 1/1000
Medium: 5% BSA in TBS-T

Incubation Time: Overnight @ 4°C
Secondary Antibody: Anti-Mouse

Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: 1 minutes

Molecular weight: 38 kDa

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
55

Aging Cytosolic heart
Film Properties Report for ERK1/2
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Primary Antibody: ERK1/2 (Cell Signal)

Duration: 45 min

Primary Antibody Dilution: 1/1000
Medium: 5% BSA in TBS-T

Incubation Time: Overnight @ 4°C
Secondary Antibody: Anti-Rabbit

Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: 15 seconds

Molecular weight: 42,44 kDa

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
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Aging Cytosolic heart
Film Properties Report for Phospho-ERK1/2
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Primary Antibody: P-Erk1/2 (Cell Signal)

Duration: 45 min

Primary Antibody Dilution: 1/1000
Medium: 5% BSA in TBS-T

Incubation Time: Overnight @ 4°C
Secondary Antibody: Anti-Mouse

Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: 1 minutes

Molecular weight: 42, 44 kDa

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
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Aging Cytosolic heart
Film Properties Report for Nonphospho-Src(Tyr527)
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Primary Antibody: Non-p-Src (Cell Signal)

Duration: 45 min

Primary Antibody Dilution: 1/1000
Medium: 5% BSA in TBS-T

Incubation Time: Overnight @ 4°C
Secondary Antibody: Anti-Rabbit

Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: 5 minutes

Molecular weight: 60 kDa

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
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Aging Cytosolic heart
Film Properties Report for Phospho-Src(tyr527)
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Primary Antibody: P- Src(tyr527) (Cell Signal)

Duration: 45 min

Primary Antibody Dilution: 1/1000
Medium: 5% BSA in TBS-T

Incubation Time: Overnight @ 4°C
Secondary Antibody: Anti-Rabbit

Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: 1 minutes

Molecular weight: 60 kDa

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
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Aging Cytosolic heart
Film Properties Report for Bax
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Primary Antibody: Bax (Santa Cruz)

Duration: 45 min

Primary Antibody Dilution: 1/1000

Incubation Time: 1hr @ Room temp
Secondary Antibody: Anti-Rabbit

Medium: 5% BSA in TBS-T
Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: 30 seconds

Molecular weight: 23 kDa

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
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Aging Cytosolic heart
Film Properties Report for Bcl-2
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Primary Antibody: Bcl-s (Santa Cruz)

Duration: 45 min

Primary Antibody Dilution: 1/1000

Incubation Time: 1hr @ Room temp
Secondary Antibody: Anti-Mouse

Medium: 5% BSA in TBS-T
Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: 4 min

Molecular weight: 26 kDa

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
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Aging Cytosolic heart
Film Properties Report for traf2
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Primary Antibody: traf2 (Santa Cruz)

Duration: 45 min

Primary Antibody Dilution: 1/1000
Medium: 5% BSA in TBS-T

Incubation Time: Overnight @ 4°C
Secondary Antibody: Anti-Rabbit

Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: 1 minutes

Molecular weight: 50 kDa

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
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Aging Cytosolic heart
Film Properties Report for HSP 27
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Primary Antibody: HSP 27 (Santa Cruz)

Duration: 45 min

Primary Antibody Dilution: 1/1000

Incubation Time: 1hr @ Room temp
Secondary Antibody: Anti-Mouse

Medium: 5% BSA in TBS-T
Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: 4 min

Molecular weight: 27 kDa

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
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Aging Cytosolic heart
Film Properties Report for HSP 70
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Primary Antibody: HSP 27 (Santa Cruz)

Duration: 45 min

Primary Antibody Dilution: 1/1000

Incubation Time: 1hr @ Room temp
Secondary Antibody: Anti-Goat

Medium: 5% BSA in TBS-T
Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: 10 min

Molecular weight: 70 kDa

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
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Aging Cytosolic heart
Film Properties Report for Nitro-Tyrosine
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Primary Antibody: Nitro-Tyrosine (Cell Signal)
Incubation Time: 1hr @ Room temp
Secondary Antibody: Anti-Rabbit

Duration: 45 min

Primary Antibody Dilution: 1/1000
Medium: 5% BSA in TBS-T
Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: 15 seconds

Molecular weight:

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
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Aging Cytosolic heart
Film Properties Report for NFkB p50
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Primary Antibody: NFkB p50 (Santa Cruz)

Duration: 45 min

Primary Antibody Dilution: 1/1000
Medium: 5% BSA in TBS-T

Incubation Time: Overnight @ 4°C
Secondary Antibody: Anti-Mouse

Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: Touch and go

Molecular weight: 50 kDa

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
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Aging Cytosolic heart
Film Properties Report for NF-Kβ p65
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Duration: 45 min

Primary Antibody: NF-Kβ p65(Cell Signal) Primary Antibody Dilution: 1/1000
Medium: 5% BSA in TBS-T

Incubation Time: Overnight @ 4°C
Secondary Antibody: Anti-Rabbit

Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: 1 hour

Molecular weight: 65 kDa

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
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Aging Cytosolic heart
Film Properties Report for Phospho-NF-Kβ p65
Experimenter: Shinichi Asano
Muscle / Tissue: Cytosolic cardiac muscle
Species: F 344/NNia x Brown Norway/BiNia rat
Protein concentration: 1.5 µg/ml
Electrophoresis Voltage: 124V

Gel type: 10% Tris-HCL SDS_PAGE
Transfer Voltage: 24V

Primary Antibody: P- NF-Kβ p65(Cell Signal)

Duration: 45 min

Primary Antibody Dilution: 1/1000
Medium: 5% BSA in TBS-T

Incubation Time: Overnight @ 4°C
Secondary Antibody: Anti-Rabbit

Secondary Antibody Dilution:1/1000
Medium: 5% milk in TBS-T

Incubation Time: 1hr@room temp
Exposure Time: 1hour

Molecular weight: 65 kDa

Lane 1: Biotinylated Ladder 16µl
Lane 2: Rainbow Marker RPN756 8 µl
Lane 3: 6month 20 µl
Lane 4: 6month 20 µl
Lane 5: 6month 20 µl
Lane 6: 30month 20 µl
Lane 7: 30month 20 µl
Lane 8: 36month 20 µl
Lane 9: 36month 20 µl
Lane 10: 36month 20 µl
Lane 11: 36month 20 µl
Lane 12: Positive control 16 µl
68

References
1.
American College of Sports Medicine Position Stand. Exercise and physical
activity for older adults. Med Sci Sports Exerc, 1998. 30(6): p. 992-1008.
2.
Stewart, S., et al., Heart failure and the aging population: an increasing burden
in the 21st century? Heart, 2003. 89(1): p. 49-53.
3.
Afanas'ev, I.B., Free radical mechanisms of aging processes under physiological
conditions. Biogerontology, 2005. 6(4): p. 283-90.
4.
Austad, S.N., Theories of aging: an overview. Aging (Milano), 1998. 10(2): p.
146-7.
5.
Frisard, M. and E. Ravussin, Energy metabolism and oxidative stress: impact on
the metabolic syndrome and the aging process. Endocrine, 2006. 29(1): p. 27-32.
6.
Barouki, R., [Ageing free radicals and cellular stress]. Med Sci (Paris), 2006.
22(3): p. 266-72.
7.
200.

Droge, W., Oxidative stress and aging. Adv Exp Med Biol, 2003. 543: p. 191-

8.
Harman, D., Aging: a theory based on free radical and radiation chemistry. J
Gerontol, 1956. 11(3): p. 298-300.
9.
Turrens, J.F. and A. Boveris, Generation of superoxide anion by the NADH
dehydrogenase of bovine heart mitochondria. Biochem J, 1980. 191(2): p. 421-7.
10.
Finkel, T., Oxidant signals and oxidative stress. Curr Opin Cell Biol, 2003. 15(2):
p. 247-54.
11.
Klein, J.A. and S.L. Ackerman, Oxidative stress, cell cycle, and
neurodegeneration. J Clin Invest, 2003. 111(6): p. 785-93.
12.
Fridlyand, L.E. and L.H. Philipson, Oxidative reactive species in cell injury:
mechanisms in diabetes mellitus and therapeutic approaches. Ann N Y Acad Sci, 2006.
1066: p. 136-51.
13.
Droge, W., Free radicals in the physiological control of cell function. Physiol
Rev, 2002. 82(1): p. 47-95.
14.
Wold, L.E., A.F. Ceylan-Isik, and J. Ren, Oxidative stress and stress signaling:
menace of diabetic cardiomyopathy. Acta Pharmacol Sin, 2005. 26(8): p. 908-17.
15.
Liu, H., et al., Redox-dependent transcriptional regulation. Circ Res, 2005.
97(10): p. 967-74.
69

16.
Torres, M., Mitogen-activated protein kinase pathways in redox signaling. Front
Biosci, 2003. 8: p. d369-91.
17.
Torres, M. and H.J. Forman, Redox signaling and the MAP kinase pathways.
Biofactors, 2003. 17(1-4): p. 287-96.
18.
Kevin, L.G., E. Novalija, and D.F. Stowe, Reactive oxygen species as mediators
of cardiac injury and protection: the relevance to anesthesia practice. Anesth Analg,
2005. 101(5): p. 1275-87.
19.
Rice, K.M., et al., Aging influences multiple incidices of oxidative stress in the
aortic media of the Fischer 344/NNiaxBrown Norway/BiNia rat. Free Radic Res, 2006.
40(2): p. 185-97.
20.
Ushio-Fukai, M., et al., p38 Mitogen-activated protein kinase is a critical
component of the redox-sensitive signaling pathways activated by angiotensin II. Role in
vascular smooth muscle cell hypertrophy. J Biol Chem, 1998. 273(24): p. 15022-9.
21.
Hwang, J.T., et al., Genistein, EGCG, and capsaicin inhibit adipocyte
differentiation process via activating AMP-activated protein kinase. Biochem Biophys
Res Commun, 2005. 338(2): p. 694-9.
22.
Bubici, C., et al., The NF-kappaB-mediated control of ROS and JNK signaling.
Histol Histopathol, 2006. 21(1): p. 69-80.
23.
Han, H., et al., Progressive apoptotic cell death triggered by transient oxidative
insult in H9c2 rat ventricular cells: a novel pattern of apoptosis and the mechanisms. Am
J Physiol Heart Circ Physiol, 2004. 286(6): p. H2169-82.
24.
Lakatta, E.G. and D. Levy, Arterial and cardiac aging: major shareholders in
cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular
disease. Circulation, 2003. 107(1): p. 139-46.
25.
Pugh, K.G. and J.Y. Wei, Clinical implications of physiological changes in the
aging heart. Drugs Aging, 2001. 18(4): p. 263-76.
26.
Lakatta, E.G., Cardiovascular regulatory mechanisms in advanced age. Physiol
Rev, 1993. 73(2): p. 413-67.
27.
Kitzman, D.W., Diastolic heart failure in the elderly. Heart Fail Rev, 2002. 7(1):
p. 17-27.
28.
Kumar, A., et al., Diastolic heart failure in the elderly and the potential role of
aldosterone antagonists. Drugs Aging, 2006. 23(4): p. 299-308.
29.
Valderrama, A.L., S.B. Dunbar, and G.A. Mensah, Atrial fibrillation: public
health implications. Am J Prev Med, 2005. 29(5 Suppl 1): p. 75-80.

70

30.
VanAuker, M.D., Age-related changes in hemodynamics affecting valve
performance. Am J Geriatr Cardiol, 2006. 15(5): p. 277-83; quiz 284-5.
31.
Lakatta, E.G., Age-associated cardiovascular changes in health: impact on
cardiovascular disease in older persons. Heart Fail Rev, 2002. 7(1): p. 29-49.
32.
Prochniewicz, E., D.D. Thomas, and L.V. Thompson, Age-related decline in
actomyosin function. J Gerontol A Biol Sci Med Sci, 2005. 60(4): p. 425-31.
33.
Thompson, L.V., et al., Myosin and actin expression and oxidation in aging
muscle. J Appl Physiol, 2006. 101(6): p. 1581-7.
34.
Fugere, N.A., D.A. Ferrington, and L.V. Thompson, Protein nitration with aging
in the rat semimembranosus and soleus muscles. J Gerontol A Biol Sci Med Sci, 2006.
61(8): p. 806-12.
35.
Lipman, R.D., et al., Pathologic characterization of brown Norway, brown
Norway x Fischer 344, and Fischer 344 x brown Norway rats with relation to age. J
Gerontol A Biol Sci Med Sci, 1996. 51(1): p. B54-9.
36.
Hacker, T.A., et al., Age-related changes in cardiac structure and function in
Fischer 344 x Brown Norway hybrid rats. Am J Physiol Heart Circ Physiol, 2006.
290(1): p. H304-11.
37.
Kohen, R. and A. Nyska, Oxidation of biological systems: oxidative stress
phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol
Pathol, 2002. 30(6): p. 620-50.
38.
Adler, A., et al., NAD(P)H oxidase-generated superoxide anion accounts for
reduced control of myocardial O2 consumption by NO in old Fischer 344 rats. Am J
Physiol Heart Circ Physiol, 2003. 285(3): p. H1015-22.
39.
Stadtman, E.R., Protein oxidation and aging. Free Radic Res, 2006. 40(12): p.
1250-8.
40.
Levine, R.L. and E.R. Stadtman, Oxidative modification of proteins during aging.
Exp Gerontol, 2001. 36(9): p. 1495-502.
41.
Olivenza, R., et al., Chronic stress induces the expression of inducible nitric oxide
synthase in rat brain cortex. J Neurochem, 2000. 74(2): p. 785-91.
42.
Prinzinger, R., Programmed ageing: the theory of maximal metabolic scope. How
does the biological clock tick? EMBO Rep, 2005. 6 Spec No: p. S14-9.
43.
59.

Hayflick, L., Theories of biological aging. Exp Gerontol, 1985. 20(3-4): p. 145-

71

44.
Franceschi, C., et al., The network and the remodeling theories of aging:
historical background and new perspectives. Exp Gerontol, 2000. 35(6-7): p. 879-96.
45.
Boeldt, E.J., Comments on proposed 40 CFR, Part 61--Standards for
Radionuclides. Health Phys, 1984. 46(6): p. 1313-4.
46.
Gius, D. and D.R. Spitz, Redox signaling in cancer biology. Antioxid Redox
Signal, 2006. 8(7-8): p. 1249-52.
47.
Manton, K.G., S. Volovik, and A. Kulminski, ROS effects on neurodegeneration
in Alzheimer's disease and related disorders: on environmental stresses of ionizing
radiation. Curr Alzheimer Res, 2004. 1(4): p. 277-93.
48.
Rolo, A.P. and C.M. Palmeira, Diabetes and mitochondrial function: role of
hyperglycemia and oxidative stress. Toxicol Appl Pharmacol, 2006. 212(2): p. 167-78.
49.

Harman, D., Free radical theory of aging. Mutat Res, 1992. 275(3-6): p. 257-66.

50.
Kamata, H. and H. Hirata, Redox regulation of cellular signalling. Cell Signal,
1999. 11(1): p. 1-14.
51.
Irani, K., Oxidant signaling in vascular cell growth, death, and survival: a review
of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic
and apoptotic signaling. Circ Res, 2000. 87(3): p. 179-83.
52.
Kyaw, M., et al., Antioxidants inhibit JNK and p38 MAPK activation but not ERK
1/2 activation by angiotensin II in rat aortic smooth muscle cells. Hypertens Res, 2001.
24(3): p. 251-61.
53.
Wu, S., et al., Activation of AP-1 through reactive oxygen species by angiotensin
II in rat cardiomyocytes. Free Radic Biol Med, 2005. 39(12): p. 1601-10.
54.
Kwon, S.H., et al., H(2)O(2) regulates cardiac myocyte phenotype via
concentration-dependent activation of distinct kinase pathways. J Mol Cell Cardiol,
2003. 35(6): p. 615-21.
55.
Pesse, B., et al., Peroxynitrite activates ERK via Raf-1 and MEK, independently
from EGF receptor and p21Ras in H9C2 cardiomyocytes. J Mol Cell Cardiol, 2005.
38(5): p. 765-75.
56.
Yoshizumi, M., K. Tsuchiya, and T. Tamaki, Signal transduction of reactive
oxygen species and mitogen-activated protein kinases in cardiovascular disease. J Med
Invest, 2001. 48(1-2): p. 11-24.
57.
Kregel, K.C., et al., HSP70 accumulation in tissues of heat-stressed rats is
blunted with advancing age. J Appl Physiol, 1995. 79(5): p. 1673-8.

72

58.
Martin, J.L., et al., Small heat shock proteins and protection against ischemic
injury in cardiac myocytes. Circulation, 1997. 96(12): p. 4343-8.
59.
Lakatta, E., Aging Effects on the Vasculature in Health: Risk Factors for
Cardiovascular Disease. Am J Geriatr Cardiol, 1994. 3(6): p. 11-17.
60.
Lakatta, E.G. and S.J. Sollott, Perspectives on mammalian cardiovascular aging:
humans to molecules. Comp Biochem Physiol A Mol Integr Physiol, 2002. 132(4): p.
699-721.
61.
Yang, X., N. Sreejayan, and J. Ren, Views from within and beyond: narratives of
cardiac contractile dysfunction under senescence. Endocrine, 2005. 26(2): p. 127-37.
62.
Pacher, P., et al., Left ventricular pressure-volume relationship in a rat model of
advanced aging-associated heart failure. Am J Physiol Heart Circ Physiol, 2004. 287(5):
p. H2132-7.
63.
Rozenberg, S., et al., Severe impairment of ventricular compliance accounts for
advanced age-associated hemodynamic dysfunction in rats. Exp Gerontol, 2006. 41(3): p.
289-95.
64.
Muscari, C., et al., Role of reactive oxygen species in cardiovascular aging. Mol
Cell Biochem, 1996. 160-161: p. 159-66.
65.
Lucas, D.T. and L.I. Szweda, Cardiac reperfusion injury: aging, lipid
peroxidation, and mitochondrial dysfunction. Proc Natl Acad Sci U S A, 1998. 95(2): p.
510-4.
66.
Pamplona, R., et al., Aging increases Nepsilon-(carboxymethyl)lysine and caloric
restriction decreases Nepsilon-(carboxyethyl)lysine and Nepsilon(malondialdehyde)lysine in rat heart mitochondrial proteins. Free Radic Res, 2002.
36(1): p. 47-54.
67.
Ji, L.L., M.C. Gomez-Cabrera, and J. Vina, Exercise and hormesis: activation of
cellular antioxidant signaling pathway. Ann N Y Acad Sci, 2006. 1067: p. 425-35.
68.
Hogg, N., Free radicals in disease. Semin Reprod Endocrinol, 1998. 16(4): p.
241-8.
69.
Wahr, P.A., D.E. Michele, and J.M. Metzger, Effects of aging on single cardiac
myocyte function in Fischer 344 x Brown Norway rats. Am J Physiol Heart Circ Physiol,
2000. 279(2): p. H559-65.
70.
Rice, K.M., et al., Aging influences multiple incidices of oxidative stress in the
aortic media of the Fischer 344/NNia x Brown Norway/BiNia rat. Free Radic Res, 2006.
40(2): p. 185-97.

73

71.
Comporti, M., Lipid peroxidation and biogenic aldehydes: from the identification
of 4-hydroxynonenal to further achievements in biopathology. Free Radic Res, 1998.
28(6): p. 623-35.
72.
Natarajan, V., W.M. Scribner, and M.M. Taher, 4-Hydroxynonenal, a metabolite
of lipid peroxidation, activates phospholipase D in vascular endothelial cells. Free Radic
Biol Med, 1993. 15(4): p. 365-75.
73.
Koppenol, W.H., Chemistry of peroxynitrite and its relevance to biological
systems. Met Ions Biol Syst, 1999. 36: p. 597-619.
74.
Hue, L., et al., New targets of AMP-activated protein kinase. Biochem Soc Trans,
2003. 31(Pt 1): p. 213-5.
75.
Naor, Z., O. Benard, and R. Seger, Activation of MAPK cascades by G-proteincoupled receptors: the case of gonadotropin-releasing hormone receptor. Trends
Endocrinol Metab, 2000. 11(3): p. 91-9.
76.
Hussein, M.R., A.K. Haemel, and G.S. Wood, Apoptosis and melanoma:
molecular mechanisms. J Pathol, 2003. 199(3): p. 275-88.
77.
Calabrese, V., et al., Regulation of heat shock protein synthesis in human skin
fibroblasts in response to oxidative stress: role of vitamin E. Int J Tissue React, 2001.
23(4): p. 127-35.
78.
Wang, T., X. Zhang, and J.J. Li, The role of NF-kappaB in the regulation of cell
stress responses. Int Immunopharmacol, 2002. 2(11): p. 1509-20.
79.
Sohal, R.S., L.A. Arnold, and B.H. Sohal, Age-related changes in antioxidant
enzymes and prooxidant generation in tissues of the rat with special reference to
parameters in two insect species. Free Radic Biol Med, 1990. 9(6): p. 495-500.
80.
Pacher, P., et al., A new, potent poly(ADP-ribose) polymerase inhibitor improves
cardiac and vascular dysfunction associated with advanced aging. J Pharmacol Exp
Ther, 2004. 311(2): p. 485-91.
81.
Bejma, J., P. Ramires, and L.L. Ji, Free radical generation and oxidative stress
with ageing and exercise: differential effects in the myocardium and liver. Acta Physiol
Scand, 2000. 169(4): p. 343-51.
82.
Genova, M.L., et al., The mitochondrial production of reactive oxygen species in
relation to aging and pathology. Ann N Y Acad Sci, 2004. 1011: p. 86-100.
83.
Brunk, U.T. and A. Terman, The mitochondrial-lysosomal axis theory of aging:
accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J
Biochem, 2002. 269(8): p. 1996-2002.

74

84.
Tanaka, K., M. Honda, and T. Takabatake, Redox regulation of MAPK pathways
and cardiac hypertrophy in adult rat cardiac myocyte. J Am Coll Cardiol, 2001. 37(2): p.
676-85.
85.
Sabri, A., H.H. Hughie, and P.A. Lucchesi, Regulation of hypertrophic and
apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxid
Redox Signal, 2003. 5(6): p. 731-40.
86.
Nakazono, K., et al., Does superoxide underlie the pathogenesis of hypertension?
Proc Natl Acad Sci U S A, 1991. 88(22): p. 10045-8.
87.
Suzuki, H., et al., In vivo evidence for microvascular oxidative stress in
spontaneously hypertensive rats. Hydroethidine microfluorography. Hypertension, 1995.
25(5): p. 1083-9.
88.
Ungvari, Z., et al., Role of oxidative-nitrosative stress and downstream pathways
in various forms of cardiomyopathy and heart failure. Curr Vasc Pharmacol, 2005. 3(3):
p. 221-9.
89.
Wei, Y.H., Oxidative stress and mitochondrial DNA mutations in human aging.
Proc Soc Exp Biol Med, 1998. 217(1): p. 53-63.
90.
Terman, A., Garbage catastrophe theory of aging: imperfect removal of oxidative
damage? Redox Rep, 2001. 6(1): p. 15-26.
91.
Terman, A. and U.T. Brunk, Lipofuscin: mechanisms of formation and increase
with age. Apmis, 1998. 106(2): p. 265-76.
92.
Terman, A. and U.T. Brunk, Myocyte aging and mitochondrial turnover. Exp
Gerontol, 2004. 39(5): p. 701-5.
93.
Zalba, G., et al., Vascular oxidant stress: molecular mechanisms and
pathophysiological implications. J Physiol Biochem, 2000. 56(1): p. 57-64.
94.
Radi, R., et al., Peroxynitrite reactions and formation in mitochondria. Free Radic
Biol Med, 2002. 33(11): p. 1451-64.
95.
Greenacre, S.A. and H. Ischiropoulos, Tyrosine nitration: localisation,
quantification, consequences for protein function and signal transduction. Free Radic
Res, 2001. 34(6): p. 541-81.
96.
Kanski, J., et al., Proteomic identification of 3-nitrotyrosine-containing rat
cardiac proteins: effects of biological aging. Am J Physiol Heart Circ Physiol, 2005.
288(1): p. H371-81.
97.
Szabo, G. and S. Bahrle, Role of nitrosative stress and poly(ADP-ribose)
polymerase activation in myocardial reperfusion injury. Curr Vasc Pharmacol, 2005.
3(3): p. 215-20.

75

98.
Pacher, P., et al., Nitrosative stress and pharmacological modulation of heart
failure. Trends Pharmacol Sci, 2005. 26(6): p. 302-10.
99.
Knowlton, A.A., et al., Differential expression of heat shock proteins in normal
and failing human hearts. J Mol Cell Cardiol, 1998. 30(4): p. 811-8.
100. Miyamoto, T., et al., Activation of distinct signal transduction pathways in
hypertrophied hearts by pressure and volume overload. Basic Res Cardiol, 2004. 99(5):
p. 328-37.
101. Nadruz, W., Jr., et al., c-Jun is regulated by combination of enhanced expression
and phosphorylation in acute-overloaded rat heart. Am J Physiol Heart Circ Physiol,
2004. 286(2): p. H760-7.
102. Vanderheyden, M., et al., Hemodynamic effects of inducible nitric oxide synthase
and nitrotyrosine generation in heart failure. J Heart Lung Transplant, 2004. 23(6): p.
723-8.
103. Kawamura, N., et al., Blockade of NF-kappaB improves cardiac function and
survival without affecting inflammation in TNF-alpha-induced cardiomyopathy.
Cardiovasc Res, 2005. 66(3): p. 520-9.
104. Takimoto, E., et al., Oxidant stress from nitric oxide synthase-3 uncoupling
stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest,
2005. 115(5): p. 1221-31.
105. Tachibana, H., et al., JNK1 is required to preserve cardiac function in the early
response to pressure overload. Biochem Biophys Res Commun, 2006. 343(4): p. 1060-6.
106. Kaiser, R.A., et al., Genetic inhibition or activation of JNK1/2 protects the
myocardium from ischemia-reperfusion-induced cell death in vivo. J Biol Chem, 2005.
280(38): p. 32602-8.
107. Lips, D.J., et al., MEK1-ERK2 signaling pathway protects myocardium from
ischemic injury in vivo. Circulation, 2004. 109(16): p. 1938-41.
108. Kunapuli, P., et al., Prostaglandin F2alpha (PGF2alpha) and the isoprostane, 8,
12-iso-isoprostane F2alpha-III, induce cardiomyocyte hypertrophy. Differential
activation of downstream signaling pathways. J Biol Chem, 1998. 273(35): p. 22442-52.
109. Dillmann, W.H., Heat shock proteins and protection against ischemic injury.
Infect Dis Obstet Gynecol, 1999. 7(1-2): p. 55-7.
110. Schafer, C., et al., HSP27 expression regulates CCK-induced changes of the actin
cytoskeleton in CHO-CCK-A cells. Am J Physiol, 1999. 277(6 Pt 1): p. C1032-43.
111. Tanonaka, K., et al., Myocardial heat shock protein changes in the failing heart
following coronary artery ligation. Heart Lung Circ, 2003. 12(1): p. 60-5.

76

112. Gosselin, K. and C. Abbadie, Involvement of Rel/NF-kappa B transcription
factors in senescence. Exp Gerontol, 2003. 38(11-12): p. 1271-83.
113. Papa, S., et al., Linking JNK signaling to NF-kappaB: a key to survival. J Cell Sci,
2004. 117(Pt 22): p. 5197-208.
114. Ha, T., et al., Attenuation of cardiac hypertrophy by inhibiting both mTOR and
NFkappaB activation in vivo. Free Radic Biol Med, 2005. 39(12): p. 1570-80.
115. Sen, C.K. and S. Roy, Relief from a heavy heart: redox-sensitive NF-kappaB as a
therapeutic target in managing cardiac hypertrophy. Am J Physiol Heart Circ Physiol,
2005. 289(1): p. H17-9.
116. Turan, B., et al., Selenium improves cardiac function by attenuating the activation
of NF-kappaB due to ischemia-reperfusion injury. Antioxid Redox Signal, 2005. 7(9-10):
p. 1388-97.
117. Spangler, E.L., et al., Behavioral assessment of aging in male Fischer 344 and
brown Norway rat strains and their F1 hybrid. Neurobiol Aging, 1994. 15(3): p. 319-28.
118. Blough, E.R. and J.K. Linderman, Lack of skeletal muscle hypertrophy in very
aged male Fischer 344 x Brown Norway rats. J Appl Physiol, 2000. 88(4): p. 1265-70.
119. Paradis, I.L. and E.J. Caldwell, Diagnostic approach to a pleural effusion. J
Maine Med Assoc, 1977. 68(10): p. 378-82.
120. Lund, D.D., et al., Gene transfer of endothelial nitric oxide synthase improves
relaxation of carotid arteries from diabetic rabbits. Circulation, 2000. 101(9): p. 102733.
121. Miller, F.J., Jr., et al., Superoxide production in vascular smooth muscle
contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res,
1998. 82(12): p. 1298-305.
122. Rothe, G., et al., Flow cytometric measurement of the respiratory burst activity of
phagocytes using dihydrorhodamine 123. J Immunol Methods, 1991. 138(1): p. 133-5.
123. Rice, K.M., et al., Effects of aging on pressure-induced MAPK activation in the
rat aorta. Pflugers Arch, 2005. 450(3): p. 192-9.

77

Curriculum Vitae
Shinichi Asano, MS, CSCS
Home:
1539 4th Avenue Apartment 9
Huntington, WV 25701
Marshall University
Phone: 304-697-6836
E-mail: asano1@marshall.edu

Office:
Laboratory of Molecular Physiology
Department of Biological Sciences,
Huntington, WV 25755
Phone: 304-696-3267
Fax: 304-696-7136

Education:
Master of Science, Biology
Emphasis in Molecular physiology
Marshall University, Huntington, West Virginia: Anticipated graduation 2007 May
Thesis: “Aging influences multiple indices of oxidative stress in the heart of the
Fischer 344/NNia x Brown Norway/BiNia rat.”
Master of Science, Exercise Science
Emphasis in Exercise Physiology
Marshall University, Huntington, West Virginia: 2005 May
Thesis: “Excess post exercise oxygen consumption and interval training”
Post Bachelor of Science, Physical Education
Emphasis in Athletic Training, transferred 2002 August
Salem International University, Salem, West Virginia
Bachelor of Arts, Intercultural Studies
Teikyo University, Tokyo, Japan: 2000 March
Work Experience:
Research Assistant, Spring 2007, Summer 2006
Dr. Eric Blough, Marshall University
Teaching Assistant, Fall 2006
Department of Biological Sciences, Marshall University
Courses: Human Physiology Lab
Teaching Assistant, Spring 2006
Department of Biological Sciences, Marshall University
Courses: Human Anatomy Lab

78

Laboratory Coordinator , Fall 2005
Division of Exercise Science, Sports & Recreation, Marshall University
Courses: Kinesiology Lab (Taught several lecture classes with Dr. Chandler)
Graduate Assistant, Fall 2004~Spring 2005
Exercise Physiology laboratory Marshall University
Graduate Assistant, Fall 2004
Division of Exercise Science, Sports & Recreation, Marshall University
Strength & Conditioning Coach
Volunteer Strength & Conditioning Coach, Sumer 2004
Athletic Department, Marshall University
Assisted Head Strength & Conditioning Coach, Football
Graduate Assistant, Spring 2004
Division of Exercise Science, Sports & Recreation, Marshall University
Staff, Diabetes Exercise Center
Graduate Assistant, Fall 2003
Division of Exercise Science, Sports & Recreation, Marshall University
Staff, Fitness Center
Publication:
Aging influences multiple indices of oxidative stress in the heart of the Fischer
344/NNia x Brown Norway/BiNia rat. Shinichi Asano, Kevin M. Rice, Sunil K.
Karkarla, and Eric R Blough, Department of Biological Sciences, Marshall
University, Department of Physiology, Marshall University, Joan C. Edwards
School of Medicine (in press)
Paper in preparation:
Altered dystrophin-glycoprotein complex composition in the aging rat heart. Sunil
K. Karkarla, Kevin M. Rice, Devashich H. Desai, Shinichi Asano and Eric R
Blough: Department of Biological Sciences, Marshall University, Department of
Physiology, Marshall University, Joan C. Edwards School of Medicine (In
preparation)
High force contraction-induced mitogen activated protein kinase (MAPK)
signaling in the rat skeletal muscle is altered in diabetes. Anjaiah Katta, Kevin M.
Rice, Deborah L. Preston, Sunil K. Kakarla, Shinichi Asano and Eric R Blough:
Department of Biological Sciences, Marshall University, Department of
Physiology, Marshall University, Joan C. Edwards School of Medicine (In
preparation)

79

Presentation:
Shinichi Asano, Kevin M Rice, Sunil K. Kakarla, Paulette S. Wehner, Ernest M.
Walker Jr., Eric R. Blough. (2006). HSPs are altered with age associated increases
in oxidative stress in the heart of the fischer 344/Nia X Brown Norway/Binia Rat.
2006 ACSM conference on Integrative Physiology of Exercise: Discovery and
Application of Cardiovascular, Pulmonary, and Metabolic Science, Indianapolis,
IN.
S. Asano, T. J. Chandler, C. E. Arnold, J. Mak, T. Shepherd. 2006 The effect of
exercise intensity on excess postexercise oxygen consumption (EPOC). 2006
Annual Meeting of Southeast American College of Sports Medicine, Charlotte,
NC.
Current Research interests:
Signal transduction mechanisms in skeletal, smooth and cardiac muscle
Research Skills:
Protein biochemistry, small animal surgery, cell culture, motility assay, metabolic
analysis, EKG interpretation,
Certifications/Memberships:
Member of American College of Sports Medicine
Member of National Strength and Conditioning Association
Certified Strength and Conditioning Specialist, certification number 200322232
American Heart Association CPR/AED
American Red Cross: Community First AID and Safety, Adult CPR
Member of US Amateur Boxing, Inc. West Virginia Association #26 48916 51 4
Awards:
2005:
1996~2000:

Taylor Scholarship Award
Variety of national level awards in boxing, including the member
of the national team

References:
Eric R. Blough, Assosciate Professor
Department of Biology
Director, Laboratory of Molecular physiology

80

Marshall University, Huntington, WV
(304)696-3267
Kazuhiro Kohama Professor, Chairman,
Department of Molecular and Cellular Pharmacology
Faculty of Medicine Gunma University Graduate School of Medicine Maebashi,
Gunma 371-8511 Japan
Phone 81-27-220-7960
E-mail kohamak@med.gunma-u.ac.jp
T. Jeff Chandler, Department Head and Professor
Department of Health, Physical Education and Recreation
Jacksonville State University, Jacksonville, Alabama
Tel: (256) 782-5514
David Mallory, Professor
Department of Biology
Marshall University, Huntington, WV
(304)696-3253
Marcia Harrison, Professor
Department of Biology
Marshall University, Huntington, WV
(304) 696-4867

81

